EAGxVirtual 2020: Mitigating catastrophic biorisks (Kevin Esvelt)

In a world now painfully aware of pandemics, with ever-increasing access to autonomous biological agents, how can we help channel society’s response to COVID-19 to minimize the risk of deliberate misuse? Using the challenge of securing DNA synthesis as an example, Kevin outlines the key norms and incentives governing biotechnology, lays out potential strategies for reform, and suggests ways in which thoughtful individuals might help safely and credibly discuss and mitigate biorisks without spreading information hazards.


Original Video

Leave a Comment

Your email address will not be published. Required fields are marked *